Avadel Pharmaceuticals plc
US ˙ NasdaqGM ˙ US05337M1045

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Deerfield Private Design Fund II, L.P.. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Deerfield Private Design Fund II, L.P. har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:AVDL / Avadel Pharmaceuticals plc 952.265
US:ALIM / Alimera Sciences, Inc. 10% Owner 728.718
US:NVLS / Nivalis Therapeutics, Inc. 10% Owner 0
US:ASPX / Auspex Pharmaceuticals, Inc. 10% Owner 0
US:DRNA / Dicerna Pharmaceuticals Inc 10% Owner 800.794
US:TRIV / TriVascular Technologies, Inc. 10% Owner 0
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Deerfield Private Design Fund II, L.P.. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb AVDL / Avadel Pharmaceuticals plc – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i AVDL / Avadel Pharmaceuticals plc. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

AVDL / Avadel Pharmaceuticals plc Insider Trades
Insidersalg AVDL / Avadel Pharmaceuticals plc – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i AVDL / Avadel Pharmaceuticals plc. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2018-06-25 AVDL Flynn James E 114.034 5,9922 114.034 5,9922 683.315 304 1.0900 -559.017 -81,81

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

AVDL / Avadel Pharmaceuticals plc Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Deerfield Private Design Fund II, L.P. som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2018-06-25 2018-06-25 4 AVDL AVADEL PHARMACEUTICALS PLC
American Depositary Shares
S - Sale -114.034 952.265 -10,69 5,99 -683.315 5.706.162
2018-05-04 3 AVDL AVADEL PHARMACEUTICALS PLC
American Depositary Shares
4.854.839
2018-05-04 3 AVDL AVADEL PHARMACEUTICALS PLC
American Depositary Shares
4.776.217
2018-05-04 3 AVDL AVADEL PHARMACEUTICALS PLC
American Depositary Shares
4.920.342
2018-05-04 3 AVDL AVADEL PHARMACEUTICALS PLC
American Depositary Shares
4.391.302
2018-05-04 3 AVDL AVADEL PHARMACEUTICALS PLC
American Depositary Shares
4.854.839
2018-05-04 3 AVDL AVADEL PHARMACEUTICALS PLC
American Depositary Shares
4.776.217
2018-05-04 3 AVDL AVADEL PHARMACEUTICALS PLC
American Depositary Shares
4.920.342
2018-05-04 3 AVDL AVADEL PHARMACEUTICALS PLC
American Depositary Shares
4.391.302
2018-05-04 3 AVDL AVADEL PHARMACEUTICALS PLC
American Depositary Shares
4.854.839
2018-05-04 3 AVDL AVADEL PHARMACEUTICALS PLC
American Depositary Shares
4.776.217
2018-05-04 3 AVDL AVADEL PHARMACEUTICALS PLC
American Depositary Shares
4.920.342
2018-05-04 3 AVDL AVADEL PHARMACEUTICALS PLC
American Depositary Shares
4.391.302
2018-05-04 3 AVDL AVADEL PHARMACEUTICALS PLC
American Depositary Shares
4.854.839
2018-05-04 3 AVDL AVADEL PHARMACEUTICALS PLC
American Depositary Shares
4.776.217
2018-05-04 3 AVDL AVADEL PHARMACEUTICALS PLC
American Depositary Shares
4.920.342
2018-05-04 3 AVDL AVADEL PHARMACEUTICALS PLC
American Depositary Shares
4.391.302
2018-05-04 3 AVDL AVADEL PHARMACEUTICALS PLC
American Depositary Shares
4.854.839
2018-05-04 3 AVDL AVADEL PHARMACEUTICALS PLC
American Depositary Shares
4.776.217
2018-05-04 3 AVDL AVADEL PHARMACEUTICALS PLC
American Depositary Shares
4.920.342
2018-05-04 3 AVDL AVADEL PHARMACEUTICALS PLC
American Depositary Shares
4.391.302
2018-05-04 3 AVDL AVADEL PHARMACEUTICALS PLC
American Depositary Shares
4.854.839
2018-05-04 3 AVDL AVADEL PHARMACEUTICALS PLC
American Depositary Shares
4.776.217
2018-05-04 3 AVDL AVADEL PHARMACEUTICALS PLC
American Depositary Shares
4.920.342
2018-05-04 3 AVDL AVADEL PHARMACEUTICALS PLC
American Depositary Shares
4.391.302
2018-05-04 3 AVDL AVADEL PHARMACEUTICALS PLC
American Depositary Shares
4.854.839
2018-05-04 3 AVDL AVADEL PHARMACEUTICALS PLC
American Depositary Shares
4.776.217
2018-05-04 3 AVDL AVADEL PHARMACEUTICALS PLC
American Depositary Shares
4.920.342
2018-05-04 3 AVDL AVADEL PHARMACEUTICALS PLC
American Depositary Shares
4.391.302
2018-05-04 3 AVDL AVADEL PHARMACEUTICALS PLC
American Depositary Shares
4.854.839
2018-05-04 3 AVDL AVADEL PHARMACEUTICALS PLC
American Depositary Shares
4.776.217
2018-05-04 3 AVDL AVADEL PHARMACEUTICALS PLC
American Depositary Shares
4.920.342
2018-05-04 3 AVDL AVADEL PHARMACEUTICALS PLC
American Depositary Shares
4.391.302
2018-05-04 3 AVDL AVADEL PHARMACEUTICALS PLC
American Depositary Shares
4.854.839
2018-05-04 3 AVDL AVADEL PHARMACEUTICALS PLC
American Depositary Shares
4.776.217
2018-05-04 3 AVDL AVADEL PHARMACEUTICALS PLC
American Depositary Shares
4.920.342
2018-05-04 3 AVDL AVADEL PHARMACEUTICALS PLC
American Depositary Shares
4.391.302
2015-12-08 2015-12-08 4 ALIM ALIMERA SCIENCES INC
Common Stock
P - Purchase 27.530 728.718 3,93 3,04 83.774 2.217.489
2015-12-08 2015-12-08 4 ALIM ALIMERA SCIENCES INC
Common Stock
P - Purchase 27.529 4.760.408 0,58 3,04 83.771 14.485.922
2015-12-08 2015-12-07 4 ALIM ALIMERA SCIENCES INC
Common Stock
P - Purchase 68.294 701.188 10,79 3,00 204.848 2.103.213
2015-12-08 2015-12-07 4 ALIM ALIMERA SCIENCES INC
Common Stock
P - Purchase 68.294 701.188 10,79 3,00 204.848 2.103.213
2015-12-08 2015-12-04 4 ALIM ALIMERA SCIENCES INC
Common Stock
P - Purchase 40.301 632.894 6,80 3,01 121.169 1.902.859
2015-12-08 2015-12-04 4 ALIM ALIMERA SCIENCES INC
Common Stock
P - Purchase 40.301 632.894 6,80 3,01 121.169 1.902.859
2015-12-03 2015-12-03 4 ALIM ALIMERA SCIENCES INC
Common Stock
P - Purchase 53.487 592.593 9,92 3,00 160.589 1.779.201
2015-12-03 2015-12-03 4 ALIM ALIMERA SCIENCES INC
Common Stock
P - Purchase 53.486 4.624.284 1,17 3,00 160.586 13.883.950
2015-12-03 2015-12-02 4 ALIM ALIMERA SCIENCES INC
Common Stock
P - Purchase 55.257 539.106 11,42 2,98 164.876 1.608.584
2015-12-03 2015-12-02 4 ALIM ALIMERA SCIENCES INC
Common Stock
P - Purchase 55.257 539.106 11,42 2,98 164.876 1.608.584
2015-12-03 2015-12-01 4 ALIM ALIMERA SCIENCES INC
Common Stock
P - Purchase 12.882 483.849 2,74 3,05 39.273 1.475.110
2015-12-03 2015-12-01 4 ALIM ALIMERA SCIENCES INC
Common Stock
P - Purchase 12.883 4.515.541 0,29 3,05 39.276 13.766.530
2015-11-10 2015-11-06 4 ALIM ALIMERA SCIENCES INC
Common Stock
P - Purchase 36.625 470.967 8,43 2,98 109.241 1.404.753
2015-11-10 2015-11-06 4 ALIM ALIMERA SCIENCES INC
Common Stock
P - Purchase 36.625 470.967 8,43 2,98 109.241 1.404.753
2015-11-03 2015-10-30 4 ALIM ALIMERA SCIENCES INC
Common Stock
P - Purchase 8.271 434.342 1,94 3,00 24.813 1.303.026
2015-11-03 2015-10-30 4 ALIM ALIMERA SCIENCES INC
Common Stock
P - Purchase 8.271 434.342 1,94 3,00 24.813 1.303.026
2015-10-29 2015-10-28 4 ALIM ALIMERA SCIENCES INC
Common Stock
P - Purchase 13.165 426.071 3,19 2,99 39.363 1.273.952
2015-10-29 2015-10-28 4 ALIM ALIMERA SCIENCES INC
Common Stock
P - Purchase 13.165 426.071 3,19 2,99 39.363 1.273.952
2015-10-29 2015-10-27 4 ALIM ALIMERA SCIENCES INC
Common Stock
P - Purchase 16.506 412.906 4,16 3,00 49.518 1.238.718
2015-10-29 2015-10-27 4 ALIM ALIMERA SCIENCES INC
Common Stock
P - Purchase 16.506 412.906 4,16 3,00 49.518 1.238.718
2015-10-26 2015-10-26 4 ALIM ALIMERA SCIENCES INC
Common Stock
P - Purchase 17.117 396.400 4,51 3,00 51.361 1.189.438
2015-10-26 2015-10-26 4 ALIM ALIMERA SCIENCES INC
Common Stock
P - Purchase 17.116 4.428.091 0,39 3,00 51.358 13.286.930
2015-10-26 2015-10-23 4 ALIM ALIMERA SCIENCES INC
Common Stock
P - Purchase 12.090 379.283 3,29 3,00 36.270 1.137.849
2015-10-26 2015-10-23 4 ALIM ALIMERA SCIENCES INC
Common Stock
P - Purchase 12.091 4.410.975 0,27 3,00 36.273 13.232.925
2015-10-26 2015-10-22 4 ALIM ALIMERA SCIENCES INC
Common Stock
P - Purchase 975 367.193 0,27 3,00 2.925 1.101.579
2015-10-26 2015-10-22 4 ALIM ALIMERA SCIENCES INC
Common Stock
P - Purchase 975 367.193 0,27 3,00 2.925 1.101.579
2015-10-21 2015-10-21 4 ALIM ALIMERA SCIENCES INC
Common Stock
P - Purchase 80.342 366.218 28,10 3,00 241.042 1.098.727
2015-10-21 2015-10-21 4 ALIM ALIMERA SCIENCES INC
Common Stock
P - Purchase 80.342 366.218 28,10 3,00 241.042 1.098.727
2015-10-21 2015-10-20 4 ALIM ALIMERA SCIENCES INC
Common Stock
P - Purchase 50.065 285.876 21,23 3,00 150.060 856.856
2015-10-21 2015-10-20 4 ALIM ALIMERA SCIENCES INC
Common Stock
P - Purchase 50.065 285.876 21,23 3,00 150.060 856.856
2015-10-21 2015-10-19 4 ALIM ALIMERA SCIENCES INC
Common Stock
P - Purchase 64.613 235.811 37,74 2,92 188.825 689.134
2015-10-21 2015-10-19 4 ALIM ALIMERA SCIENCES INC
Common Stock
P - Purchase 64.613 235.811 37,74 2,92 188.825 689.134
2015-10-09 2015-10-09 4 ALIM ALIMERA SCIENCES INC
Common Stock
P - Purchase 71.540 171.198 71,79 2,53 180.710 432.446
2015-10-09 2015-10-09 4 ALIM ALIMERA SCIENCES INC
Common Stock
P - Purchase 71.540 171.198 71,79 2,53 180.710 432.446
2015-10-09 2015-10-08 4 ALIM ALIMERA SCIENCES INC
Common Stock
P - Purchase 19.817 99.658 24,82 2,50 49.542 249.145
2015-10-09 2015-10-08 4 ALIM ALIMERA SCIENCES INC
Common Stock
P - Purchase 19.816 4.131.349 0,48 2,50 49.540 10.328.372
2015-10-09 2015-10-07 4 ALIM ALIMERA SCIENCES INC
Common Stock
P - Purchase 69.536 79.841 674,78 2,30 159.724 183.395
2015-10-09 2015-10-07 4 ALIM ALIMERA SCIENCES INC
Common Stock
P - Purchase 69.536 79.841 674,78 2,30 159.724 183.395
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
8.483.188
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.451.496
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.622.413
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.648.858
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
8.483.188
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.451.496
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.622.413
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.648.858
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
8.483.188
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.451.496
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.622.413
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.648.858
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
8.483.188
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.451.496
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.622.413
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.648.858
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
8.483.188
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.451.496
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.622.413
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.648.858
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
8.483.188
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.451.496
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.622.413
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.648.858
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
8.483.188
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.451.496
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.622.413
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.648.858
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
8.483.188
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.451.496
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.622.413
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.648.858
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
8.483.188
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.451.496
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.622.413
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.648.858
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
8.483.188
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.451.496
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.622.413
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.648.858
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
8.483.188
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.451.496
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.622.413
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.648.858
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
8.483.188
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.451.496
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.622.413
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.648.858
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
8.483.188
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.451.496
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.622.413
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.648.858
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
8.483.188
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.451.496
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.622.413
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.648.858
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
8.483.188
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.451.496
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.622.413
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.648.858
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
8.483.188
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.451.496
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.622.413
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.648.858
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
8.483.188
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.451.496
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.622.413
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.648.858
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
8.483.188
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.451.496
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.622.413
2015-10-09 3 ALIM ALIMERA SCIENCES INC
Common Stock
4.648.858
2015-06-25 2015-06-23 4 NVLS Nivalis Therapeutics, Inc.
Series 2 Preferred Stock
C - Conversion -936.839 0 -100,00
2015-06-25 2015-06-23 4 NVLS Nivalis Therapeutics, Inc.
Series 2 Preferred Stock
C - Conversion -817.541 0 -100,00
2015-06-25 2015-06-23 4 NVLS Nivalis Therapeutics, Inc.
Series 2 Preferred Stock
C - Conversion -85.962 0 -100,00
2015-06-25 2015-06-23 4 NVLS Nivalis Therapeutics, Inc.
Series 2 Preferred Stock
C - Conversion -54.385 0 -100,00
2015-06-25 2015-06-23 4 NVLS Nivalis Therapeutics, Inc.
Series 2 Preferred Stock
C - Conversion -385.962 0 -100,00
2015-06-25 2015-06-23 4 NVLS Nivalis Therapeutics, Inc.
Series 1 Preferred Stock
C - Conversion -1.243.423 0 -100,00
2015-06-25 2015-06-23 4 NVLS Nivalis Therapeutics, Inc.
Series 1 Preferred Stock
C - Conversion -1.085.085 0 -100,00
2015-06-25 2015-06-23 4 NVLS Nivalis Therapeutics, Inc.
Series 1 Preferred Stock
C - Conversion -1.401.003 0 -100,00
2015-06-25 2015-06-23 4 NVLS Nivalis Therapeutics, Inc.
Series 1 Preferred Stock
C - Conversion -869.667 0 -100,00
2015-06-25 2015-06-23 4 NVLS Nivalis Therapeutics, Inc.
Series 1 Preferred Stock
C - Conversion -2.013.613 0 -100,00
2015-06-25 2015-06-23 4 NVLS Nivalis Therapeutics, Inc.
Common Stock
P - Purchase 77.539 832.216 10,27 14,00 1.085.546 11.651.024
2015-06-25 2015-06-23 4 NVLS Nivalis Therapeutics, Inc.
Common Stock
P - Purchase 67.666 726.242 10,27 14,00 947.324 10.167.388
2015-06-25 2015-06-23 4 NVLS Nivalis Therapeutics, Inc.
Common Stock
P - Purchase 104.795 1.124.740 10,27 14,00 1.467.130 15.746.360
2015-06-25 2015-06-23 4 NVLS Nivalis Therapeutics, Inc.
Common Stock
C - Conversion 324.278 754.677 75,34
2015-06-25 2015-06-23 4 NVLS Nivalis Therapeutics, Inc.
Common Stock
C - Conversion 282.984 658.576 75,34
2015-06-25 2015-06-23 4 NVLS Nivalis Therapeutics, Inc.
Common Stock
C - Conversion 29.755 647.152 4,82
2015-06-25 2015-06-23 4 NVLS Nivalis Therapeutics, Inc.
Common Stock
C - Conversion 18.825 402.062 4,91
2015-06-25 2015-06-23 4 NVLS Nivalis Therapeutics, Inc.
Common Stock
C - Conversion 133.597 1.019.945 15,07
2015-06-25 2015-06-23 4 NVLS Nivalis Therapeutics, Inc.
Common Stock
C - Conversion 430.399 430.399
2015-06-25 2015-06-23 4 NVLS Nivalis Therapeutics, Inc.
Common Stock
C - Conversion 375.592 375.592
2015-06-25 2015-06-23 4 NVLS Nivalis Therapeutics, Inc.
Common Stock
C - Conversion 484.944 617.397 366,13
2015-06-25 2015-06-23 4 NVLS Nivalis Therapeutics, Inc.
Common Stock
C - Conversion 301.027 383.237 366,17
2015-06-25 2015-06-23 4 NVLS Nivalis Therapeutics, Inc.
Common Stock
C - Conversion 696.993 886.348 368,09
2015-06-16 3 NVLS Nivalis Therapeutics, Inc.
Common Stock
486.233
2015-06-16 3 NVLS Nivalis Therapeutics, Inc.
Common Stock
536.475
2015-06-16 3 NVLS Nivalis Therapeutics, Inc.
Common Stock
593.380
2015-06-16 3 NVLS Nivalis Therapeutics, Inc.
Common Stock
486.233
2015-06-16 3 NVLS Nivalis Therapeutics, Inc.
Common Stock
536.475
2015-06-16 3 NVLS Nivalis Therapeutics, Inc.
Common Stock
593.380
2015-06-16 3 NVLS Nivalis Therapeutics, Inc.
Common Stock
486.233
2015-06-16 3 NVLS Nivalis Therapeutics, Inc.
Common Stock
536.475
2015-06-16 3 NVLS Nivalis Therapeutics, Inc.
Common Stock
593.380
2015-06-16 3 NVLS Nivalis Therapeutics, Inc.
Common Stock
486.233
2015-06-16 3 NVLS Nivalis Therapeutics, Inc.
Common Stock
536.475
2015-06-16 3 NVLS Nivalis Therapeutics, Inc.
Common Stock
593.380
2015-06-16 3 NVLS Nivalis Therapeutics, Inc.
Common Stock
486.233
2015-06-16 3 NVLS Nivalis Therapeutics, Inc.
Common Stock
536.475
2015-06-16 3 NVLS Nivalis Therapeutics, Inc.
Common Stock
593.380
2015-06-16 3 NVLS Nivalis Therapeutics, Inc.
Common Stock
486.233
2015-06-16 3 NVLS Nivalis Therapeutics, Inc.
Common Stock
536.475
2015-06-16 3 NVLS Nivalis Therapeutics, Inc.
Common Stock
593.380
2015-06-16 3 NVLS Nivalis Therapeutics, Inc.
Common Stock
486.233
2015-06-16 3 NVLS Nivalis Therapeutics, Inc.
Common Stock
536.475
2015-06-16 3 NVLS Nivalis Therapeutics, Inc.
Common Stock
593.380
2015-06-16 3 NVLS Nivalis Therapeutics, Inc.
Common Stock
486.233
2015-06-16 3 NVLS Nivalis Therapeutics, Inc.
Common Stock
536.475
2015-06-16 3 NVLS Nivalis Therapeutics, Inc.
Common Stock
593.380
2015-06-16 3 NVLS Nivalis Therapeutics, Inc.
Common Stock
486.233
2015-06-16 3 NVLS Nivalis Therapeutics, Inc.
Common Stock
536.475
2015-06-16 3 NVLS Nivalis Therapeutics, Inc.
Common Stock
593.380
2015-05-07 2015-05-05 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
U - Other -973.379 0 -100,00
2015-05-07 2015-05-05 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
U - Other -849.426 0 -100,00
2015-05-07 2015-05-05 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
U - Other -1.182.943 0 -100,00
2015-05-07 2015-05-05 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
U - Other -953.286 0 -100,00
2015-05-07 2015-05-05 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
U - Other -490.069 0 -100,00
2015-01-28 2015-01-28 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
P - Purchase 192.240 973.379 24,61 56,50 10.861.560 54.995.914
2015-01-28 2015-01-28 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
P - Purchase 167.760 849.426 24,61 56,50 9.478.440 47.992.569
2015-01-28 2015-01-28 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
P - Purchase 566.825 1.182.943 92,00 56,50 32.025.612 66.836.280
2015-01-28 2015-01-28 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
P - Purchase 458.175 953.286 92,54 56,50 25.886.888 53.860.659
2015-01-28 2015-01-28 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
P - Purchase 115.000 490.069 30,66 56,50 6.497.500 27.688.898
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3.324.172
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3.444.214
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3.565.221
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3.630.769
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3.730.242
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3.324.172
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3.444.214
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3.565.221
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3.630.769
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3.730.242
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3.324.172
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3.444.214
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3.565.221
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3.630.769
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3.730.242
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3.324.172
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3.444.214
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3.565.221
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3.630.769
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3.730.242
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3.324.172
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3.444.214
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3.565.221
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3.630.769
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3.730.242
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3.324.172
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3.444.214
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3.565.221
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3.630.769
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3.730.242
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3.324.172
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3.444.214
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3.565.221
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3.630.769
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3.730.242
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3.324.172
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3.444.214
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3.565.221
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3.630.769
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3.730.242
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3.324.172
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3.444.214
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3.565.221
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3.630.769
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3.730.242
2014-11-25 2014-11-25 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale -55.035 800.794 -6,43 11,50 -632.902 9.209.131
2014-11-25 2014-11-25 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale -48.027 698.822 -6,43 11,50 -552.310 8.036.453
2014-11-25 2014-11-25 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale -18.903 275.046 -6,43 11,50 -217.384 3.163.029
2014-11-25 2014-11-24 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale -3.785 855.829 -0,44 11,54 -43.679 9.876.267
2014-11-25 2014-11-24 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale -3.303 746.849 -0,44 11,54 -38.117 8.618.637
2014-11-25 2014-11-24 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale -14.199 293.949 -4,61 11,55 -163.998 3.395.111
2014-11-25 2014-11-24 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale -41.339 859.614 -4,59 11,55 -477.465 9.928.542
2014-11-25 2014-11-24 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale -36.074 750.152 -4,59 11,55 -416.655 8.664.256
2014-11-25 2014-11-24 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale -1.300 308.148 -0,42 11,54 -15.002 3.556.028
2014-11-25 2014-11-21 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale -45.124 900.953 -4,77 11,00 -496.364 9.910.483
2014-11-25 2014-11-21 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale -39.377 786.226 -4,77 11,00 -433.147 8.648.486
2014-11-25 2014-11-21 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale -15.499 309.448 -4,77 11,00 -170.489 3.403.928
2014-11-10 2014-11-07 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale -30.100 0 -100,00 9,33 -280.833
2014-11-10 2014-11-07 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale -3.500 30.100 -10,42 9,27 -32.445 279.027
2014-11-10 2014-11-07 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale -180.564 33.600 -84,31 9,00 -1.625.076 302.400
2014-10-15 2014-10-15 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale -51.449 214.164 -19,37 10,01 -515.004 2.143.782
2014-10-15 2014-10-14 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale -14.464 946.077 -1,51 11,02 -159.393 10.425.769
2014-10-15 2014-10-14 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale -12.622 825.603 -1,51 11,02 -139.094 9.098.145
2014-10-15 2014-10-14 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale -4.061 265.613 -1,51 11,02 -44.752 2.927.055
2014-10-15 2014-10-14 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale -4.968 324.947 -1,51 11,02 -54.747 3.580.916
2014-10-15 2014-10-10 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale -246 960.541 -0,03 12,00 -2.952 11.528.413
2014-10-15 2014-10-10 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale -215 838.225 -0,03 12,00 -2.580 10.060.376
2014-10-15 2014-10-10 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale -69 269.674 -0,03 12,00 -828 3.236.627
2014-10-15 2014-10-10 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale -84 330 -20,29 12,00 -1.008 3.960
2014-10-15 2014-10-10 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale -11.855 960.787 -1,22 12,14 -143.860 11.659.150
2014-10-15 2014-10-10 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale -10.345 838.440 -1,22 12,14 -125.537 10.174.469
2014-10-15 2014-10-10 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale -3.328 269.743 -1,22 12,14 -40.385 3.273.331
2014-10-15 2014-10-10 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale -4.072 329.999 -1,22 12,14 -49.414 4.004.538
2014-04-22 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Series E Preferred Stock
C - Conversion -253.384 0 -100,00
2014-04-22 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Series E Preferred Stock
C - Conversion -221.118 0 -100,00
2014-04-22 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Series E Preferred Stock
C - Conversion -71.333 0 -100,00
2014-04-22 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Series E Preferred Stock
C - Conversion -86.834 0 -100,00
2014-04-22 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Common Stock
P - Purchase 75.480 261.143 40,65 11,97 903.126 3.124.602
2014-04-22 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Common Stock
P - Purchase 94.520 324.524 41,09 11,97 1.130.941 3.882.962
2014-04-22 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Common Stock
P - Purchase 19.980 185.663 12,06 12,29 245.468 2.281.000
2014-04-22 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Common Stock
P - Purchase 25.020 230.004 12,21 12,29 307.388 2.825.760
2014-04-22 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Common Stock
P - Purchase 340.425 593.809 134,35 12,00 4.085.100 7.125.708
2014-04-22 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Common Stock
P - Purchase 297.075 518.193 134,35 12,00 3.564.900 6.218.316
2014-04-22 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Common Stock
P - Purchase 94.350 165.683 132,27 12,00 1.132.200 1.988.196
2014-04-22 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Common Stock
P - Purchase 118.150 204.984 136,06 12,00 1.417.800 2.459.808
2014-04-22 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Common Stock
C - Conversion 253.384 253.384
2014-04-22 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Common Stock
C - Conversion 221.118 221.118
2014-04-22 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Common Stock
C - Conversion 71.333 71.333
2014-04-22 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Common Stock
C - Conversion 86.834 86.834
2014-02-11 2014-02-10 4 ASPX Auspex Pharmaceuticals, Inc.
Series E Preferred Stock
C - Conversion -2.323.086 0 -100,00
2014-02-11 2014-02-10 4 ASPX Auspex Pharmaceuticals, Inc.
Series E Preferred Stock
C - Conversion -2.027.262 0 -100,00
2014-02-11 2014-02-10 4 ASPX Auspex Pharmaceuticals, Inc.
Series E Preferred Stock
C - Conversion -654.002 0 -100,00
2014-02-11 2014-02-10 4 ASPX Auspex Pharmaceuticals, Inc.
Series E Preferred Stock
C - Conversion -796.114 0 -100,00
2014-02-11 2014-02-10 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
P - Purchase 280.350 796.591 54,31 12,00 3.364.200 9.559.092
2014-02-11 2014-02-10 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
P - Purchase 244.650 695.152 54,31 12,00 2.935.800 8.341.824
2014-02-11 2014-02-10 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
P - Purchase 78.400 223.733 53,95 12,00 940.800 2.684.796
2014-02-11 2014-02-10 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
P - Purchase 96.600 273.514 54,60 12,00 1.159.200 3.282.168
2014-02-11 2014-02-10 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
C - Conversion 516.241 796.591 184,14
2014-02-11 2014-02-10 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
C - Conversion 450.502 695.152 184,14
2014-02-11 2014-02-10 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
C - Conversion 145.333 223.733 185,37
2014-02-11 2014-02-10 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
C - Conversion 176.914 273.514 183,14
2014-02-04 2014-02-04 4 DRNA Dicerna Pharmaceuticals Inc
Series C Preferred Stock
C - Conversion -572.142 0 -100,00
2014-02-04 2014-02-04 4 DRNA Dicerna Pharmaceuticals Inc
Series C Preferred Stock
C - Conversion -499.285 0 -100,00
2014-02-04 2014-02-04 4 DRNA Dicerna Pharmaceuticals Inc
Series C Preferred Stock
C - Conversion -161.071 0 -100,00
2014-02-04 2014-02-04 4 DRNA Dicerna Pharmaceuticals Inc
Series C Preferred Stock
C - Conversion -196.071 0 -100,00
2014-02-04 2014-02-04 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
P - Purchase 400.500 972.642 70,00 15,00 6.007.500 14.589.630
2014-02-04 2014-02-04 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
P - Purchase 349.500 848.785 70,00 15,00 5.242.500 12.731.775
2014-02-04 2014-02-04 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
P - Purchase 112.000 273.071 69,53 15,00 1.680.000 4.096.065
2014-02-04 2014-02-04 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
P - Purchase 138.000 334.071 70,38 15,00 2.070.000 5.011.065
2014-02-04 2014-02-04 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
C - Conversion 572.142 972.642 142,86
2014-02-04 2014-02-04 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
C - Conversion 499.285 848.785 142,86
2014-02-04 2014-02-04 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
C - Conversion 161.071 273.071 143,81
2014-02-04 2014-02-04 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
C - Conversion 196.071 334.071 142,08
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)